The Global Thrombectomy
Devices Market, by Product Type (Mechanical Thrombectomy Devices,
Aspiration Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, and
Ultrasonic Thrombectomy Devices), by Application (Neurovascular,
Cardiovascular, and Peripheral Vascular), and by End User (Hospitals,
Ambulatory Surgical Centers, and Research Laboratories and Academic
Institutes), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) was valued at US$ 1.03 billion in 2017, and is
projected to exhibit a CAGR of 7.4% during the forecast period (2018 - 2026).
Thrombectomy procedure is indicated for
patients with acute ischemic stroke caused due to blockage in one or more large
arteries in the brain. People already treated with intravenous thrombolysis
that has not been effective, can also be treated with the help of thrombectomy
procedures. Thrombectomy approaches have evolved rapidly due to rising
technological advancements of catheters as well as thrombectomy device such as
intra-arterial thrombolytic infusions, which enable higher recanalization rates
than before. Manufacturers are focused on gaining maximum product approval and
innovating existing products in order to gain market share. In May 2018,
Stryker Corporation received an expanded CE Mark approval in the European Union
for its Trevo thrombectomy device as a front-line treatment for acute ischemic
stroke patients.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2254
In August 2018, NexGen Medical
Systems, Inc., completed the first human use of their XCOIL Large Vessel (18mm)
Thrombectomy System for the treatment of deep vein thrombosis (DVT). The new
device, an expansion of the successful XCOIL 12mm System, is designed to
rapidly remove blood clots in large vessels, such as the iliac vein. In May
2017, SurModics acquired Embolitech’s thrombectomy platform and the associated
intellectual property in a deal worth US$ 5 million, with additional payments
based on regulatory milestones.
Browse 30 Market Data Tables and
33 Figures spread through 194 Pages and in-depth TOC on "Thrombectomy
Devices Market, by Product Type (Mechanical Thrombectomy Devices, Aspiration
Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, and Ultrasonic
Thrombectomy Devices), by Application (Neurovascular, Cardiovascular, and
Peripheral Vascular), and by End User (Hospitals, Ambulatory Surgical Centers,
and Research Laboratories and Academic Institutes), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global
Forecast to 2026"
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/thrombectomy-devices-market-2254
Key Takeaways of the thrombectomy
devices Market:
The global thrombectomy devices
market is expected to expand at a CAGR of 7.4% during the forecast period
(2018–2026), owing to increasing incidence of stroke and thrombosis, and rising
technological advancement in thrombectomy devices. For instance, in 2016,
Penumbra Inc., announced the U.S. commercial availability of its most advanced
thrombectomy device, ACE68 Reperfusion Catheter. The product leverages the
latest advancements in tracking technology to deliver maximum aspiration power
easily and safely for extracting thrombus in acute ischemic stroke patients.
Major players operating in the
global thrombectomy devices market include Applied Medical, Argon Medical
Devices, Inc., Boston Scientific Corporation, BTG International, Capture
Vascular, Claret Medical, Control Medical Technology, Edwards Lifesciences
Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc.,
Minnetronix, Inc., Nexgen Medical Systems, Inc., Natec Medical Ltd., Penumbra,
Inc., Phenox GmbH, Stentys SA, Spectranetics Corporation, Straub Medical AG,
Stryker Corporation, Terumo Corporation, and Teleflex Incorporated.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2254
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment